ANDRZEJEWSKI STEPHEN J 4
4 · KING PHARMACEUTICALS INC · Filed Feb 19, 2009
Insider Transaction Report
Form 4
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
- Award
Long-Term Performance Unit
2009-02-17+39,000→ 39,000 totalExp: 2010-12-31→ Common Stock (39,000 underlying)
Footnotes (3)
- [F1]Each Long-Term Performance Unit represents a contingent right to receive one share of King Pharmaceuticals, Inc. common stock.
- [F2]The number of Long-Term Performance Units awarded was based on the achievement of certain 2008 annual earnings per share targets established in early 2008.
- [F3]The Long-Term Performance Units vest in full on December 31, 2010, contingent upon the reporting person's continuing to be employed by King Pharmaceuticals, Inc. as of that date.